These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38773664)
1. Barriers to diverse clinical trial participation in Duchenne muscular dystrophy: Engaging Hispanic/Latina caregivers and health professionals. Crossnohere NL; Campoamor NB; Camino E; Dresnick E; Martschenko DO; Rodrigues V; Apkon S; Hazlett A; Mittur D; Rodriguez PE; Bridges JFP; Armstrong N Orphanet J Rare Dis; 2024 May; 19(1):207. PubMed ID: 38773664 [TBL] [Abstract][Full Text] [Related]
2. Involving South Asian patients in clinical trials. Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164 [TBL] [Abstract][Full Text] [Related]
3. Perceptions about dementia clinical trials among underrepresented populations: a nationally representative survey of U.S. dementia caregivers. Leggins B; Hart DM; Jackson AJ; Levenson RW; Windon CC; Merrilees J; Chiong W Alzheimers Res Ther; 2024 Oct; 16(1):224. PubMed ID: 39407319 [TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders. Peay HL; Biesecker BB; Wilfond BS; Jarecki J; Umstead KL; Escolar DM; Tibben A Clin Trials; 2018 Apr; 15(2):139-148. PubMed ID: 29475375 [TBL] [Abstract][Full Text] [Related]
5. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Cruz-Flores S; Rabinstein A; Biller J; Elkind MS; Griffith P; Gorelick PB; Howard G; Leira EC; Morgenstern LB; Ovbiagele B; Peterson E; Rosamond W; Trimble B; Valderrama AL; ; ; ; Stroke; 2011 Jul; 42(7):2091-116. PubMed ID: 21617147 [TBL] [Abstract][Full Text] [Related]
6. Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy. Bendixen RM; Morgenroth LP; Clinard KL Clin Ther; 2016 Jun; 38(6):1474-1484.e2. PubMed ID: 27136712 [TBL] [Abstract][Full Text] [Related]
7. Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trials. Furlong P; Dugar A; White M Res Involv Engagem; 2024 Jan; 10(1):1. PubMed ID: 38167117 [TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy. Mann JR; Zhang Y; McDermott S; Wang Y; Cai B; Conway KM; Paramsothy P; Royer J; Venkatesh S; Howard JF; Ciafaloni E; Neuroepidemiology; 2023; 57(2):90-99. PubMed ID: 36623491 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP? Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674 [TBL] [Abstract][Full Text] [Related]
12. Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients. Paquin RS; Fischer R; Mansfield C; Mange B; Beaverson K; Ganot A; Martin AS; Morris C; Rensch C; Ricotti V; Russo LJ; Sadosky A; Smith EC; Peay HL Orphanet J Rare Dis; 2019 May; 14(1):102. PubMed ID: 31072340 [TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers. Zhu Y; Romitti PA; Conway KM; Andrews J; Liu K; Meaney FJ; Street N; Puzhankara S; Druschel CM; Matthews DJ Pediatr Neurol; 2014 Jul; 51(1):71-7. PubMed ID: 24785967 [TBL] [Abstract][Full Text] [Related]
14. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy. Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756 [TBL] [Abstract][Full Text] [Related]
15. Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy. Denger B; Kinnett K; Martin A; Grant S; Armstrong C; Khodyakov D Orphanet J Rare Dis; 2019 Aug; 14(1):205. PubMed ID: 31429780 [TBL] [Abstract][Full Text] [Related]
17. Using an Online, Modified Delphi Approach to Engage Patients and Caregivers in Determining the Patient-Centeredness of Duchenne Muscular Dystrophy Care Considerations. Khodyakov D; Grant S; Denger B; Kinnett K; Martin A; Booth M; Armstrong C; Dao E; Chen C; Coulter I; Peay H; Hazlewood G; Street N Med Decis Making; 2019 Nov; 39(8):1019-1031. PubMed ID: 31722623 [No Abstract] [Full Text] [Related]
18. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis. Allison K; Patel DG; Greene L JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274 [TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic disparities in access to community-based perinatal mental health programs: results from a cross-sectional survey. Rokicki S; Patel M; Suplee PD; D'Oria R BMC Public Health; 2024 Apr; 24(1):1094. PubMed ID: 38643069 [TBL] [Abstract][Full Text] [Related]